2022 Neurovascular Accessory Devices Pipeline Report: Featuring Achieva Medical, Alcyone Lifesciences, Artiria Medical and BaseCamp Vascular Among Others - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 10, 2022--
The "Neurovascular Accessory Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report has been added to ResearchAndMarkets.com's offering.
Scope
- Extensive coverage of the Neurovascular Accessory Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Neurovascular Accessory Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Neurovascular Accessory Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Key Topics Covered:
1 Table of Contents
2 Introduction
2.1 Neurovascular Accessory Devices Overview
3 Products under Development
3.1 Neurovascular Accessory Devices - Pipeline Products by Stage of Development
3.2 Neurovascular Accessory Devices - Pipeline Products by Segment
3.3 Neurovascular Accessory Devices - Pipeline Products by Territory
3.4 Neurovascular Accessory Devices - Pipeline Products by Regulatory Path
3.5 Neurovascular Accessory Devices - Pipeline Products by Estimated Approval Date
3.6 Neurovascular Accessory Devices - Ongoing Clinical Trials
4 Neurovascular Accessory Devices - Pipeline Products under Development by Companies
4.1 Neurovascular Accessory Devices Companies - Pipeline Products by Stage of Development
4.2 Neurovascular Accessory Devices - Pipeline Products by Stage of Development
5 Neurovascular Accessory Devices Companies and Product Overview
5.1 Achieva Medical (Shanghai) Co Ltd Company Overview
5.2 Alcyone Lifesciences Inc Company Overview
5.3 Artiria Medical SA Company Overview
5.4 BaseCamp Vascular Company Overview
5.5 Bendit Technologies Ltd Company Overview
5.6 Boston University School of Medicine Company Overview
5.7 EchoGuide Medical, Inc. (Inactive) Company Overview
5.8 Hansen Medical Inc (Inactive) Company Overview
5.9 HeMo Bioengineering Ltd Company Overview
5.10 Hibernia Medical Company Overview
5.11 Irras AB Company Overview
5.12 Medikit Co Ltd Company Overview
5.13 MicroPort Scientific Corp Company Overview
5.14 MicroVention Inc Company Overview
5.15 Navisonics Inc Company Overview
5.16 Neurosyntec LLC. (Inactive) Company Overview
5.17 Occam Design LLC Company Overview
5.18 Peijia Medical Ltd Company Overview
5.19 Q'Apel Medical LLC Company Overview
5.20 Sensome SAS Company Overview
5.21 Shanghai HeartCare Medical Technology Co Ltd Company Overview
5.22 Shanghai Pulse Medical Technology Inc Company Overview
5.23 Shenzhen Century MicroPort Medical Technology Co Ltd Company Overview
5.24 Terumo Corp Company Overview
5.25 Twin Star Medical Inc Company Overview
5.26 University of California Los Angeles Company Overview
5.27 University of California San Diego Company Overview
5.28 University of Pennsylvania Company Overview
5.29 University of Pittsburgh Company Overview
5.30 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
6 Neurovascular Accessory Devices- Recent Developments
7 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/4u0nv2
Source: GlobalData
View source version on businesswire.com:https://www.businesswire.com/news/home/20221110005580/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH GENERAL HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2022.